Pediatric cancer prediction is taking a significant leap forward with the advent of artificial intelligence tools that analyze brain scans over time.A groundbreaking study from Harvard reveals that AI-driven methods outperform traditional techniques in predicting the risk of relapse for children diagnosed with gliomas, a challenging type of brain tumor.